These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23891089)

  • 1. Residual γH2AX foci predict local tumour control after radiotherapy.
    Koch U; Höhne K; von Neubeck C; Thames HD; Yaromina A; Dahm-Daphi J; Baumann M; Krause M
    Radiother Oncol; 2013 Sep; 108(3):434-9. PubMed ID: 23891089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residual gammaH2AX foci in head and neck squamous cell carcinomas as predictors for tumour radiosensitivity: Evaluation in pre-clinical xenograft models and clinical specimens.
    Meneceur S; Löck S; Gudziol V; Hering S; Bütof R; Rehm M; Baumann M; Krause M; von Neubeck C
    Radiother Oncol; 2019 Aug; 137():24-31. PubMed ID: 31048234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparable radiation response of ex vivo and in vivo irradiated tumor samples determined by residual γH2AX.
    Rassamegevanon T; Löck S; Baumann M; Krause M; von Neubeck C
    Radiother Oncol; 2019 Oct; 139():94-100. PubMed ID: 31445839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual DNA double strand breaks in perfused but not in unperfused areas determine different radiosensitivity of tumours.
    Menegakis A; Eicheler W; Yaromina A; Thames HD; Krause M; Baumann M
    Radiother Oncol; 2011 Jul; 100(1):137-44. PubMed ID: 21821302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor heterogeneity determined with a γH2AX foci assay: A study in human head and neck squamous cell carcinoma (hHNSCC) models.
    Rassamegevanon T; Löck S; Range U; Krause M; Baumann M; von Neubeck C
    Radiother Oncol; 2017 Sep; 124(3):379-385. PubMed ID: 28739384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of γH2AX Foci Increases in Ex Vivo Biopsies Relative to In Vivo Tumors.
    Rassamegevanon T; Löck S; Baumann M; Krause M; von Neubeck C
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30181446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation.
    Yaromina A; Krause M; Thames H; Rosner A; Krause M; Hessel F; Grenman R; Zips D; Baumann M
    Radiother Oncol; 2007 Jun; 83(3):304-10. PubMed ID: 17517444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. γH2AX assay in ex vivo irradiated tumour specimens: A novel method to determine tumour radiation sensitivity in patient-derived material.
    Menegakis A; von Neubeck C; Yaromina A; Thames H; Hering S; Hennenlotter J; Scharpf M; Noell S; Krause M; Zips D; Baumann M
    Radiother Oncol; 2015 Sep; 116(3):473-9. PubMed ID: 25866027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of a correlation between γH2AX foci kinetics in lymphocytes and the severity of acute normal tissue reactions during IMRT treatment for head and neck cancer.
    Werbrouck J; Duprez F; De Neve W; Thierens H
    Int J Radiat Biol; 2011 Jan; 87(1):46-56. PubMed ID: 21142613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual γH2AX foci after ex vivo irradiation of patient samples with known tumour-type specific differences in radio-responsiveness.
    Menegakis A; De Colle C; Yaromina A; Hennenlotter J; Stenzl A; Scharpf M; Fend F; Noell S; Tatagiba M; Brucker S; Wallwiener D; Boeke S; Ricardi U; Baumann M; Zips D
    Radiother Oncol; 2015 Sep; 116(3):480-5. PubMed ID: 26297183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the tumour bed effect on microenvironment, radiobiological hypoxia and the outcome of fractionated radiotherapy of human FaDu squamous-cell carcinoma growing in the nude mouse.
    Zips D; Eicheler W; Brüchner K; Jackisch T; Geyer P; Petersen C; van der Kogel AJ; Baumann M
    Int J Radiat Biol; 2001 Dec; 77(12):1185-93. PubMed ID: 11747543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different classes of EGFR inhibitors may have different potential to improve local tumour control after fractionated irradiation: a study on C225 in FaDu hSCC.
    Krause M; Schütze C; Petersen C; Pimentel N; Hessel F; Harstrick A; Baumann M
    Radiother Oncol; 2005 Feb; 74(2):109-15. PubMed ID: 15734198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of [(18)F]FMISO stratified dose-escalation on local control in FaDu hSCC in nude mice.
    Schütze C; Bergmann R; Brüchner K; Mosch B; Yaromina A; Zips D; Hessel F; Krause M; Thames H; Kotzerke J; Steinbach J; Baumann M; Beuthien-Baumann B
    Radiother Oncol; 2014 Apr; 111(1):81-7. PubMed ID: 24636842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of clonogenic cell survival curves based on the number of residual DNA double strand breaks measured by gammaH2AX staining.
    Menegakis A; Yaromina A; Eicheler W; Dörfler A; Beuthien-Baumann B; Thames HD; Baumann M; Krause M
    Int J Radiat Biol; 2009 Nov; 85(11):1032-41. PubMed ID: 19895280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR-amplification plus gene expression profiling predicts response to combined radiotherapy with EGFR-inhibition: A preclinical trial in 10 HNSCC-tumour-xenograft models.
    Koi L; Löck S; Linge A; Thurow C; Hering S; Baumann M; Krause M; Gurtner K
    Radiother Oncol; 2017 Sep; 124(3):496-503. PubMed ID: 28807520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations.
    Zumsteg ZS; Morse N; Krigsfeld G; Gupta G; Higginson DS; Lee NY; Morris L; Ganly I; Shiao SL; Powell SN; Chung CH; Scaltriti M; Baselga J
    Clin Cancer Res; 2016 Apr; 22(8):2009-19. PubMed ID: 26589432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. gammaH2AX expression in tumors exposed to cisplatin and fractionated irradiation.
    Bañuelos CA; Banáth JP; Kim JY; Aquino-Parsons C; Olive PL
    Clin Cancer Res; 2009 May; 15(10):3344-53. PubMed ID: 19401347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential value of the neutral comet assay and γH2AX foci assay in assessing the radiosensitivity of carbon beam in human tumor cell lines.
    Zhao J; Guo Z; Zhang H; Wang Z; Song L; Ma J; Pei S; Wang C
    Radiol Oncol; 2013; 47(3):247-57. PubMed ID: 24133390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring the response of human head and neck squamous cell carcinoma to irradiation in a microfluidic model allowing customized therapy.
    Cheah R; Srivastava R; Stafford ND; Beavis AW; Green V; Greenman J
    Int J Oncol; 2017 Oct; 51(4):1227-1238. PubMed ID: 28902347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous and radiation-induced expression of gammaH2AX in biopsies from patients treated for carcinoma of the uterine cervix.
    Olive PL; Banuelos CA; Durand RE; Kim JY; Aquino-Parsons C
    Radiother Oncol; 2010 Jan; 94(1):82-9. PubMed ID: 19903578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.